Velcade cytoxan dexamethasoe (VCD) or velcade thalidomide dexamethasone (VTD) induction regimens for newly diagnosed multiple myeloma-which regimen should we prefer?

Category Systematic review
JournalHaematologica
Year 2012
This article has no abstract
Epistemonikos ID: d7d11e00ca2059333c7a2f43af9f65b5e22b2a2c
First added on: Feb 06, 2025